Combined androgen blockade for the treatment of metastatic cancer of the prostate

This publication has 33 references indexed in Scilit:

• Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patients
  The Lancet, 1995
• Overview analysis issues using combined androgen deprivation overview analysis as an example
  Urologic Oncology: Seminars and Original Investigations, 1995
• A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer
  Urology, 1995
• Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)
  Urology, 1993
• Risk Factors for Prostate Cancer
  Annals of Internal Medicine, 1993
• Carcinoma of the Prostate
  New England Journal of Medicine, 1991
• Cancer in the European community and its member states
  European Journal of Cancer and Clinical Oncology, 1990
• A Phase III Trial of Zoladex and Flutamide Versus Orchiectomy in the Treatment of Patients With Advanced Carcinoma of the Prostate
  Cancer, 1990
• A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
  New England Journal of Medicine, 1989
• STUDIES ON PROSTATIC CANCER
  Archives of Surgery, 1941